'teratogens' related content
Editorial content matching 'teratogens'
Content with tags matching 'teratogens':
353 days ago - PR Newswire: Mining & Metals
TORONTO AND JOHANNESBURG, May 30, 2012 /PRNewswire/ - Independent proxy advisory firm Glass, Lewis & Co., LLC recommended today that shareholders of First Uranium Corpor...
354 days ago - PR Newswire: Mining & Metals
All amounts are in US dollars unless otherwise noted. TORONTO and JOHANNESBURG, May 28, 2012 /PRNewswire/ - First Uranium Corporation (TSX:FIU), (JSE:FUM) (ISIN:CA33744R1029) ...
360 days ago - PR Newswire: Banking & Financial Services
NEW YORK, May 23, 2012 /PRNewswire/ -- Dahlman Rose & Company, LLC, a leading investment bank specializing in the global natural resources supply chain, will host...
360 days ago - PR Newswire: Mining & Metals
NEW YORK, May 23, 2012 /PRNewswire/ -- Dahlman Rose & Company, LLC, a leading investment bank specializing in the global natural resources supply chain, will host...
362 days ago - PR Newswire: Mining & Metals
NYSE MKT Equities Exchange Symbol - UEC CORPUS CHRISTI, TX, May 21, 2012 /PRNewswire/ - Uranium Energy Corp. (NYSE MKT: UEC, the "Company" or "UEC") is pleased to provide an ...
367 days ago - PR Newswire: Mining & Metals
TSXV: UAX OTCQX: ATURF VANCOUVER, May 16, 2012 /PRNewswire/ - Athabasca Uranium Inc. ("Athabasca" or the "Company") is pleased to report the completion of its spring 2...
372 days ago - PR Newswire: Mining & Metals
Toronto Stock Exchange (TSX): CVV VANCOUVER, May 11, 2012 /PRNewswire/ - CanAlaska Uranium Ltd. (TSX: CVV) ("CanAlaska" or the "Company") is pleased to repor...
373 days ago - PR Newswire: Mining & Metals
TSXV: UAX OTCQX: ATURF VANCOUVER, May 10, 2012 /PRNewswire/ - Athabasca Uranium Inc. ("Athabasca" or the "Company") is pleased to announce the engagement of SEMM Loggin...
375 days ago - PR Newswire: Mining & Metals
All amounts are in US dollars unless otherwise noted. TORONTO AND JOHANNESBURG, May 8, 2012 /PRNewswire/ - First Uranium Corporation (TSX:FIU), (JSE:FUM) (ISIN:CA33744R1029) ...
375 days ago - BBC News - Business
Drug firm Abbott Laboratories agrees to pay out $1.6bn (£1bn) after improperly marketing mood-stabilising drug Depakote.